Mary J. Fidler, MD

Mary J. Fidler, MD is a thoracic oncologist and professor in Internal Medicine at Rush Medical Center with an emphasis on lung cancer treatment. She has extensive clinical experience treating early and late stage lung cancer patients. Fidler is the national principal investigator for the ADAURA trial which is studying post-operative osimertinib in resected EGFR + lung cancer patients, and is the institutional principal investigator for several stage III and IV lung cancer clinical trials.